Home / Intelligence / News

Search

New Report from Trinity Highlights Key Barriers to U.S. Biosimilar Adoption

Complex Pricing Structures, Legal and Regulatory Barriers, and Clinical Uncertainty Hinder Progress in Biosimilar Market Access Key findings from the report, which seeks to reveal opportunities to accelerate biosimilar adoption, include the following: Biosimilar pricing to date has not offered the sharp discounts payers expect, after accounting for contract discounts and nuances such as the “rebate trap”; Biologic innovators have taken legal and promotional actions that derail biosimilar commercial success; Providers are not fully comfortable with biosimilars and are interested…

Read Now

Trinity Director of Advanced Analytics, Todd Foster to Attend PMSA’s Winter Symposium

Todd Foster, Trinity’s director of advanced analytics, will attend the PMSA’s Multi-Channel Marketing Symposium in Las Vegas, January 18 – 19 2018. During the event, Todd will meet with fellow industry leaders to discuss innovative marketing practices that use data to elevate multi-channel marketing for the biotechnology, medical and pharmaceutical industries. Learn more about the event here: http://bit.ly/2FIL3MS…

Read Now

Senior Partner Leslie Sandberg Orne Discusses Top Drugs for 2018

In a recent article for Formulary Watch, editor Christine Blank spoke with Trinity’s Leslie Sandberg Orne about new blockbuster drugs to hit the marketplace in 2018 that will treat HIV, diabetes, cancer, migraine headaches and other conditions. Check out Leslie’s insights in the full article, here: http://bit.ly/2ArPeZz…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.